Current prescribing patterns for hypertension and atherosclerotic cardiovascular disease (ASCVD) in MSF programmes and their association with treatment outcomes and renal function: could there be a role for fixed dose combination drugs?

Principal investigator

Locations

Zimbabwe, Jordan, Lebanon, Eswatini
Topic

Non-communicable diseases
Methodology

Observational study
Reference

OCA018-66
Views

239
Downloaded

0

Purpose of study

The purpose of the study is to inform the revision of guidelines for hypertension and ASCVD care in MSF noncommmunicble (NCD) disease projects, to simplify treatment for both patient and prescriber, in order to improve overall medication use (pres...

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

2018_CN_Retropsective_Hypertension_AR.docx 35.4 KB

Publications

Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation

Murphy, Adrianna "–" Springer Science and Business Media LLC "(2022)"
Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases

Webster, Ruth "–" Ubiquity Press, Ltd. "(2020)"
Addressing Failures in Achieving Hypertension Control in Low- and Middle-Income Settings through Simplified Treatment Algorithms

Cohn, Jennifer "–" Ubiquity Press, Ltd. "(2022)"

Previous study

Next study